Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
It's down because its earnings basically suck. Add to that lots of promises without follow through. Not a whole lot of love out there for this stock.
I assume everything we are being told is not true. That would be consistent with our experience over the past year and a half.
I have worthless stock that is unlisted. If the stock ever gets relisted and starts trading at a price greater than zero I'll consider it my investment. Right now it is one person's investment, first name starts with "K".
I listened to the video. Kevin has said and promised a lot of things, NONE of which have come to pass. When the stock starts trading I'll believe it. Until then I consider what he says to be meaningless. Remember Kaseya, EPA and the White House? No mention of them anymore.
He's offering an investment opportunity?! What was the $15K I invested in his company about?
The only thing I pay attention to now is results.
By "he" I assume you mean Kevin. Exactly how is he looking out for us?
Finally, a voice in the wilderness.
Clearly, someone or a number of people found out what we've known for a while. The CEO's letter to shareholders https://www.hemacare.com/wp-content/uploads/2018/05/2017-Annual-Report_Final.pdf is a worthwhile read, especially this line-- "we continue transforming HemaCare to become the preferred supplier of human biological materials supporting immunotherapy, cell therapy, and regenerative medicine worldwide. We look forward to maximizing the future of the company and all the potential it holds". Their industry is predicted to have a $2.5B market value in 2024.
They are more than doubling their operational space, increasing efficiency of product development, expanding to a far greater degree into markets worldwide and buying new state of the art equipment.
I have no idea what the shares will be selling for in 2 years but given that the company is under the radar and has yet to be up listed (I believe they are focusing on growing the company and will let the share price take care of itself, rather than focusing attention where it's not needed at the moment), the future could be as exciting as what we've experienced over the past 2 years.
Could someone please explain what the news release is saying and its implications for the long term? Seems complicated. Tlhanks in advance.
I guess we'll have to agree to disagree. He needs to be doing BOTH, now. He had an entire year to get it together and we are where we are. The damage that has been done is because the due diligence necessary to ensure that listing continued was not performed. I want Kevin to also focus on relisting and getting the fins together because he has not done so in the past. The time to start on that process is now because we have plenty of evidence of that not happening when there was an opportunity to do so.
What he believes and what ensues has been 180 degrees opposite. There is an expression-- "If you keep on riding in the same direction eventually you will get there." I hope he finds someone who is both knowledgeable and competent to help him steer the company in a direction that allows it to be resurrected.
Maybe for you it is a "moot" point, but not for me. It is one of two critical points. If his business booms and our shares are worthless what will be a moot point is the success of his business.
Do you (or anyone else) know why while he gave great detail about the business, when he talked about relisting he only briefly mentioned looking at multiple pathways for being relisted rather than providing us with an idea of the paths they are pursuing?
I agree with everything you said except "I could see . . . a Pharmaceutical co. buying this stock."
The company has zero value to a rx company other than perhaps the equipment for processing hemp into CBD. The caveats are if what they have is state of the art, i.e., it produces research and medicinal grade product and can process enough product fast enough and in enough volume to be of interest to a pharmaceutical company.
But a great post. What you talk about happens all too often in the sub-penny marketplace.
In answer to my own question as to what the IRS would see as the value of ABHI the answer is zero. Up until last Friday TD Ameritrade showed a share price of .0003. Today it shows 0.00. The total value in my account for ABHI is no longer indicated with a total loss shown of everything I invested into the stock.
Not to get into a tit-for-tat-- I'm wondering if being annoyed that the owner of a once publicly traded company whose shareholders now find their stock valueless spends 15 seconds of a ~4 minute update addressing what is of most concern to his shareholders? I'm giving him a break that he may not have been lying when saying the fins would be out by the end of 2017 by saying he was inept. I'm hanging in there, for now, and yes I hope for the best. I have more invested in ABHI than most people so perhaps my upsetness is in parallel with the number of shares I own.
I'll let it go from now forward. Despite what I just wrote your point is well taken.
The more I listen to what he says the more I think he is inept rather than dishonest. His years of business failures attest to that. Ten years of Voosh and nothing to show for it. Remember when he was talking about how many millions of dollars just the code was worth? That was so crazy it could only have been spoken by someone who was absolutely clueless.
I have to find out, in terms of writing the stock down to zero, if it's considered zero now that it's not trading. The issue is that if the IRS considers the stock worthless this year and I don't put it on my 2018 tax return and the stock remains valueless I will have to modify my 2018 tax return in a future year to show the loss in 2018. Not a huge deal and if one believes ABHI will come back to life or doesn't need the tax loss this year those may be reasonable reasons to wait.
I went to the part about potential relisting in about 10 seconds of rapidly clicking along the update video timeline. How HIS company is doing is like hearing about how a pizza place in Brooklyn is doing in their business. I know. He says one needs to show the SEC that you have a bona fide business before a company can relist. He spent 10 seconds on that part of the story which from my perspective is the only part of the story that matters. The rest of it was how Kevin, no matter what, may stand to make a lot of money. Nice, but doesn't help us. You know, fool me once shame on you, fool me twice . . . . This guy has been talking out of his butt for over a year. When I see something that is factually and substantively positive I'll believe what he's saying, which wasn't much relative to the angst and loss of money of his "shareholders".
What's missing is his expression of concern for his shareholders who put down their money in belief that his company would be filing its financials to get itself up-to-date and have a highly successful, i.e., profitable business. He had to have known that staying listed was not going to happen. I would have hoped he would have said something that demonstrates that he feels our pain and he and his "team" are working hard at getting themselves relisted. It sounded more as an aside than a committed and concerted effort.
> Could GW start suing CBD oil sellers?
CBD oil sellers are not competition for GW. Insurance companies will not pay a cent for unapproved CBD oil products. The cost of treatment will be astronomical, upwards of 25m/kg/day. I'll let you do the math.
As long as CBD oil sellers are not making structure or function claims they can sell their product. Notice that a dose is never suggested by CBD oil purveyors. Just something like start with 25mg (how many times a day?) and increase as needed. CBD oil's value other than in an approved product is anecdotal; that is why claims cannot be made.
I guess there's a slight risk the FDA could say CBD oil companies are selling an unapproved drug but the doses most people are taking are not even on the scale of what is in the approved drug. Also, the risks associated with taking CBD oil while present are low for most people. It has to do with certain liver metabolic pathways that are blocked; that's an issue for people taking drugs metabolized by the liver but I don't know how much one has to take before that is an issue. If the FDA thought it was a significant risk they would have already blocked the sale of CBD oil.
How's Kevin doing with the relisting of the company?
Only joking. The decision to sell the shares in my regular account to my brokerage firm will need to be done by the end of the year. They will buy the worthless shares at .01.
If the Ledger Gazette is saying it, it must be true.
I made about $12K in UBQU before I sold all my shares. At one point I was up $25K. I lost $15K in ABHI. I believed what the CEO of ABHI said. They had extraordinary software. Soon they would be current. I was going to make a fortune. There were signs that things were wrong but my hope for striking it rich blinded me. I blinded myself. No one can tell you what to do, as you know. Perhaps the answer is to not go all in and if it goes up you make good money but if it doesn't make it at least you don't lose what was a wildly hopeful large investment.
I would be happy to get back my initial $15K investment.
Agreed. I think Kevin will, if not already, become a ghost.
Anyone old enough to remember the TV show Racket Squad? Go to 24:40
In 2017 HEMA had $20M in revenue. In 2015 they estimated the market for their products and services to be $500M with an expected tripling of that market by 2025. During 2018 they will be increasing the number of employees, moving to a much larger facility, moving into new markets and purchasing new equipment to prepare for the continuing and increasing demand for their products and services. In 2018 growth is expected to less than the previous 3 years due to the aforementioned capital expenditures. However, this is clearly an undiscovered gem in the biotech industry. With only 12M shares outstanding the stock could readily skyrocket over the next few years. A move to NASDAQ will hopefully occur in the not too distant future, however, they have mentioned nothing in that regard as of today.
I worked at the FDA in a senior-level position for 10 years. What you are suggesting is not the way it works when it comes to clinical trials. Regardless, I placed my bet and we'll see what happens.
Perhaps this is what you are saying, but the only way they are getting to .25 in the near future without FDA approval (which will take it's time in coming given where they are at in their clinical trials) is via a r/s. I'm not sure how a higher stock price and or reverse split will help them get funding. If the stock price is higher without a reverse split it will be for good reason and that will attract new investors. If they do a reverse split, while the stock price will be higher the company valuation will remain unchanged. .25 or .01 will not matter to investors. They are not looking at stock price. It's a company that will make it big or go bankrupt, as I said in an earlier message. The likelihood of success is what will get them the $.
> Not that impressed with the current lack commercialization'
Radiogel is not approved by the FDA. It can't be commercialized.
I generally ignore what CEOs promise, especially in these tiny companies. They tend not to have the professionalism of more experienced CEOs who promise nothing and don't give dates. That's a mistake that can only lead to a drain on investor confidence as we've seen.
The lack of financing is what kills biotech startups like RDGL. It's a race between product approval and no $. If RadioGel is approved and is wildly effective then we make a lot of money. Otherwise, we go to zero. That's the game.
I saw that on the gummy bear manufacturer's website, as well. I couldn't find anything that said what percentage of the consumers of gummies are also the target population for CBD oil although UBQU initially marketed their gummies to children and probably for good reason (that's who really loves gummies). I did convince them, as many of you know, that for numerous reasons they would be putting a target on their back for both the DEA and FDA by doing that. They have since backed off on that ridiculous marketing idea.
If anyone here winds up buying them I'd be curious to hear what they think of the gummies. Are they like gummy bears or something else? How do they taste and what is the consistency? Do they work for you as well as the oil taken directly?
Why do you think gummy bears will be a hit? I know no adults that who eat gummies. High in sugar, bad for one's teeth. I don't get the appeal other than one can readily self-medicate throughout the day. Maybe it will be a good thing except those who most need it can't afford it. But if they had CBD-laden oatmeal chocolate chip cookies . . .
It was selling opportunity for those who wanted to get out. Lots of people wanting to buy the stock from them. These kinds of stocks are the wrong stocks for people who have little patience and don't know what it means to hold a stock for years before there's a payoff.
This is an important first step. They have now shown, although in just one animal for now, that the Radiogel stays (at least it seems the vast majority of it) within the confines of the tumor. Regardless of my two qualifications it is an important move forward.
Next we see how the tumor is impacted by the Radiogel and whether there is increase in the lifespan/quality of life of the animal relative to non-treatment due to tumors that cannot be treated surgically. Often sarcomas become imbedded in the muscle layer of the animal. There is no way to resect those tumors hence the incredible positive impact that radiogel could have in canines and felines (and perhaps one day in humans).
It sounds like management has little idea of how to run a publicly traded company. I'm not willing to stick around to see if they learn their business on my dime. To many other great investment opportunities out there. I hope you all make a fortune! GLTA.
Press release. https://finance.yahoo.com/news/hemplife-today-experiences-over-200-113000067.html
Nothing of great impact, IMHO. As an aside, the writing quality reminds me of the article written last week about UBQU.
Said the person who said to me "Good for you."
My point is, in case you missed it, that until and IF Kevin gets the company relisted then anything he says is absolutely meaningless for me as a "shareholder" and is only, at this time, of potential benefit to him. Given his business batting average of zero I'm not hopeful. I made the mistake of believing what he said. Never again. Only results matter going forward.
Not good for me or you. Good for Kevin.
I'll get excited about his new whatever when shares have value. That way we'll get to participate in his success.
Yes, I mentioned that in an earlier post. If people want them and see them as a good value they will sell. Of course, first they need to be for sale. Perhaps the gummies will make their appearance at around the same time as Cryptobuy.
It may say 30mg gummies but how much is available for absorption when in a gummy? To the degree the information in this link is correct, check https://madebyhemp.com/what-is-the-bioavailability-of-cbd/
I think the gummies are an incredibly ridiculous product. What purpose do they serve? The dose will be so tiny that they will do nothing (assuming they stick to their 5 - 10mg/gummy statement in their original press release when they were marketing to children; I wrote to them relentlessly about that and they finally stopped that nonsense). Also, there is a HUGE difference between ingesting the oil and taking a gummy. And no one knows what that difference is! By definition, i.e., the carrier of the CBD oil, there must be a difference. This is what happens when you have non-medical/non-scientists at the helm. However, reality may have no impact on stock price. It's perception that counts and if potential buyers of the product (and the stock) think this is great stuff then the share price will go higher.
That's a good point. His software has never yielded a profit for him other than the unknown amount of the lawsuit settlement. He never would have teamed up with the losers at ABHI if he had any kind of business sense.
The law firm keeps about 18%. Whatever we get it is more than the zero we have now and the zero we will have in the future. If a stock is actively trading then a class action suit is more risky. The stock can go down in price so one suffers a double loss-- the loss incurred due to whatever the reason is for the lawsuit and the loss due to the class action suit, itself. I don't think we have to worry about the stock going down any further so that risk is eliminated.
For those of you who know more than I on the subject, is a class action lawsuit possible against AmbiCom/Kevin for releasing forward-looking positive videos and press releases that had many statements that we now know were not true? He made a lot of promises on which people based their investment that were never kept. It would take a legal team to discover if he made those statements actually believing what he was saying or if he was purposely misleading. I'm not sure that even matters. How does one, without causing personal financial ruin, go about starting a class action lawsuit if others agree that it is warranted?